Amundi Acquires 1,839,045 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Amundi boosted its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 70.3% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,455,720 shares of the pharmacy operator’s stock after acquiring an additional 1,839,045 shares during the quarter. Amundi owned 0.52% of Walgreens Boots Alliance worth $41,082,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Farther Finance Advisors LLC boosted its holdings in shares of Walgreens Boots Alliance by 56.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 5,831 shares of the pharmacy operator’s stock worth $52,000 after purchasing an additional 2,094 shares in the last quarter. Principal Financial Group Inc. boosted its holdings in shares of Walgreens Boots Alliance by 2.9% in the 3rd quarter. Principal Financial Group Inc. now owns 886,144 shares of the pharmacy operator’s stock worth $7,940,000 after purchasing an additional 24,974 shares in the last quarter. CWA Asset Management Group LLC purchased a new position in shares of Walgreens Boots Alliance in the 3rd quarter worth about $106,000. Sigma Planning Corp boosted its holdings in shares of Walgreens Boots Alliance by 4.2% in the 3rd quarter. Sigma Planning Corp now owns 31,632 shares of the pharmacy operator’s stock worth $283,000 after purchasing an additional 1,282 shares in the last quarter. Finally, Crossmark Global Holdings Inc. boosted its holdings in shares of Walgreens Boots Alliance by 16.5% in the 3rd quarter. Crossmark Global Holdings Inc. now owns 56,647 shares of the pharmacy operator’s stock worth $508,000 after purchasing an additional 8,031 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

WBA has been the subject of a number of research reports. Royal Bank of Canada upped their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a report on Wednesday, January 15th. Evercore ISI upped their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a report on Monday, January 13th. Truist Financial cut their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a report on Friday, January 31st. Wolfe Research upgraded Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Finally, Bank of America increased their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Four analysts have rated the stock with a sell rating, eight have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $11.54.

Walgreens Boots Alliance Trading Down 0.1 %

NASDAQ WBA opened at $11.20 on Thursday. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $22.05. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The stock has a 50 day simple moving average of $10.75 and a two-hundred day simple moving average of $9.74. The stock has a market cap of $9.68 billion, a P/E ratio of -1.09, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. During the same quarter last year, the business posted $0.66 EPS. The business’s revenue was up 7.6% on a year-over-year basis. On average, analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.